An observational study in Septic Arthritis of the Native Hip and Epiphyseal Arrest, Lower Leg, sponsored by Assiut University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-01-07.
Sponsored by Assiut University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Absence or loss of the growth plate together with the epiphysis of a long bone presents a very difficult condition to treat. An example of this is the loss of the head and neck of the femur especially as a part of severe sequelae of infantile septic arthritis.
Ever since its advent by Taylor in 1975 , the vascularized fibular free flap has gained popularity and became the gold standard to reconstruct challenging bony defects of the head, neck and extremities. Vascularized fibular flaps offer a great deal of versatility, particularly when reconstructing bony defects larger than 6 cm. In skeletally immature patients, vascularized epiphyseal transfer allows for reconstruction of complex bony defects preserving ongoing longitudinal growth, and provides a reliable articular surface for effective joint function. Although the proximal fibular growth plate is the most popular type of transfer. Therefore, it's mandatory to assess follow up of patients underwent epiphyseal transfer.
Earlier reports of proximal fibular epiphyseal transfer described the use of the peroneal vessels as the pedicle, However the results were overall disappointing and the peroneal artery alone was concluded to be insufficient to support the physeal growth plate. A bipedicled transfer, using the peroneal vessels to support the diaphysis and the anterior tibial vessels or the inferior lateral genicular vessels to support the epiphysis was attempted. Although this showed better outcomes, it was technically more demanding and had a higher risk of complications. Taylor reported the use of the anterior tibial vessels as a single pedicle with success after confirming its role in the blood supply of the fibular diaphysis and epiphysis in a cadaveric study. Another study further popularized the use of the anterior tibial pedicle after introducing the "reverse flow" method and describing the harvest technique. A reported drawback for the use of the anterior tibial pedicle was the occasional need to transect branches of the deep peroneal nerve during the harvest due to their complex relation to the vessels.
This variability in the vascular pedicle employed mandated to the need for a detailed anatomical study of the blood supply of the proximal fibula including the head region, and the supplying vessels, in order to give surgeons appropriate information for choosing the ideal vessel for these complex cases and minimize donor site morbidity. To the best of our knowledge, no such study has been conducted or published in the literature. Moreover, no study has described the anatomic relationship of the deep peroneal nerve branches to the tibialis anterior muscle and their relation to the supplying vessels, which represents another obstacle in the face of popularizing this highly beneficial technique.
Absence or loss of the growth plate together with the epiphysis of a long bone presents a very difficult condition to treat. An example of this is the loss of the head and neck of the femur especially as a part of severe sequelae of infantile septic arthritis. Another example is congenital radial longitudinal deficiency with a previously failed centralization procedure. Management strategies of these and similar problematic conditions are limited and unsatisfactory, with major residual functional disability. Vascularized epiphyseal transfer presents a potential solution to such problems.
51 studies on the registry are indexed under Arthritis, Infectious; 12 are open to participants now.
This study's planned enrollment of 20 is below the median of 100 across 30 observational studies indexed under Arthritis, Infectious.
Browse Arthritis, Infectious studies →Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Functional outcome of the hip.
• Bone union will be evaluated according to de Boer et al in 1989
Time frame: 5 years
functional outcome
The Oxford Hip Score (OHS) for hip function
Time frame: 5 years
No study locations are listed for this record.
Start is estimated for Dec 2025; primary completion for Dec 2028, 35 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.